The company said Friday it develops medicines designed to precisely target disease pathology with an initial emphasis on the innate immune system. Odyssey said its most advanced programs include ...

Walmart (NYSE:WMT) unveiled its new corporate logo this week, in the company's first redesign since 2008. Although very ...

J.F. Lehman & Company ("JFLCO"), a leading middle-market private investment firm focused exclusively on the aerospace, defense, maritime, government and ...

Telix Pharmaceuticals Limited ASX TLX Nasdaq TLX Telix the Company today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb Inc ImaginAb to acquire a ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 12, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase ...

Jefferies analyst Stephen Volkmann maintained a Buy rating on Ingersoll Rand (IR – Research Report) yesterday and set a price target of ...

Jefferies analyst Robert Dickerson reiterated a Buy rating on McCormick & Company (MKC – Research Report) today and set a price target of ...

The trading platform is seeking a $5 billion valuation and could list as soon as the second quarter, the Financial Times said ...

Analysts at Jefferies have moved to the sidelines on social media platform Pinterest (NYSE:PINS) and downgraded the stock to ...

TOKYO (Reuters) -Japan's Nintendo will release the Switch 2 console, successor to its hit Switch device, this year, it said ...

Jefferies downgraded Constellation to Hold from Buy, lowering the price target to $201 from $310, pointing to the company's recent struggles, including a broad miss across all segments and reduced ...

Jefferies downgraded Constellation to Hold from Buy, lowering the price target to $201 from $310, pointing to the company's recent struggles, including a broad miss across all segments and reduced ...